The University of Southampton
University of Southampton Institutional Repository

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial

Objective: To evaluate whether a particular group of women with intrahepatic cholestasis of pregnancy (ICP), based on their presenting characteristics, would benefit from treatment with ursodeoxycholic acid (UDCA). Design: Secondary analysis of the PITCHES trial (ISRCTN91918806). Setting: United Kingdom. Population or Sample: 527 women with ICP. Methods: Subgroup analyses were performed to determine whether baseline bile acid concentrations or baseline itch scores moderated a woman’s response to treatment with UDCA. Main outcome measures: Bile acid concentration and itch score. Results: In women with baseline bile acid concentrations less than 40 μmol/l, treatment with UDCA resulted in increased post-randomisation bile acid concentrations (geometric mean ratio 1.19, 95% CI 1.00–1.41, P = 0.048). A test of interaction showed no significance (P = 0.647). A small, clinically insignificant difference was seen in itch response in women with a high baseline itch score (–6.0 mm, 95% CI −11.80 to −0.21, P = 0.042), with a test of interaction not showing significance (P = 0.640). Further subgroup analyses showed no significance. Across all women there was a weak relationship between bile acid concentrations and itch severity. Conclusions: There was no subgroup of women with ICP in whom a beneficial effect of treatment with UDCA on bile acid concentration or itch score could be identified. This confirms that its routine use in women with this condition for improvement of bile acid concentration or itch score should be reconsidered. Tweetable abstract: PITCHES: No group of women with ICP has been found in whom UDCA reduces bile acid concentrations or pruritus.

Cholestasis, perinatal, pregnancy, stillbirth, ursodeoxycholic acid
1470-0328
1066-1075
Fleminger, J.
ce06d3c6-36e5-487c-bad5-ed32eb011637
Seed, P. T.
d3eda3f4-0e4c-4c17-9efd-dc75b583e79a
Smith, A.
68a16a6a-b4cd-4546-80f1-fdba0e0a0cec
Juszczak, Edmund
9267758e-8ab8-44c7-ab14-48ef82fa6b6e
Dixon, P. H.
57197420-4a59-4992-8932-d60a38e05bd8
Chambers, J.
4d91cc48-9ff4-4bf1-a5fc-94ba0292aba9
Dorling, J.
e55dcb9a-a798-41a1-8753-9e9ff8aab630
Williamson, Catherine
8aff4e42-f30c-4f1e-81ce-d4e9266a5a2f
Thornton, J. G.
9edbe61e-ce9e-4f02-9536-cedeb0257bf9
Chappell, L. C.
43bf7847-01bc-4c93-a8b1-a63f18f3a51e
Fleminger, J.
ce06d3c6-36e5-487c-bad5-ed32eb011637
Seed, P. T.
d3eda3f4-0e4c-4c17-9efd-dc75b583e79a
Smith, A.
68a16a6a-b4cd-4546-80f1-fdba0e0a0cec
Juszczak, Edmund
9267758e-8ab8-44c7-ab14-48ef82fa6b6e
Dixon, P. H.
57197420-4a59-4992-8932-d60a38e05bd8
Chambers, J.
4d91cc48-9ff4-4bf1-a5fc-94ba0292aba9
Dorling, J.
e55dcb9a-a798-41a1-8753-9e9ff8aab630
Williamson, Catherine
8aff4e42-f30c-4f1e-81ce-d4e9266a5a2f
Thornton, J. G.
9edbe61e-ce9e-4f02-9536-cedeb0257bf9
Chappell, L. C.
43bf7847-01bc-4c93-a8b1-a63f18f3a51e

Fleminger, J., Seed, P. T., Smith, A., Juszczak, Edmund, Dixon, P. H., Chambers, J., Dorling, J., Williamson, Catherine, Thornton, J. G. and Chappell, L. C. (2021) Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128 (6), 1066-1075. (doi:10.1111/1471-0528.16567).

Record type: Article

Abstract

Objective: To evaluate whether a particular group of women with intrahepatic cholestasis of pregnancy (ICP), based on their presenting characteristics, would benefit from treatment with ursodeoxycholic acid (UDCA). Design: Secondary analysis of the PITCHES trial (ISRCTN91918806). Setting: United Kingdom. Population or Sample: 527 women with ICP. Methods: Subgroup analyses were performed to determine whether baseline bile acid concentrations or baseline itch scores moderated a woman’s response to treatment with UDCA. Main outcome measures: Bile acid concentration and itch score. Results: In women with baseline bile acid concentrations less than 40 μmol/l, treatment with UDCA resulted in increased post-randomisation bile acid concentrations (geometric mean ratio 1.19, 95% CI 1.00–1.41, P = 0.048). A test of interaction showed no significance (P = 0.647). A small, clinically insignificant difference was seen in itch response in women with a high baseline itch score (–6.0 mm, 95% CI −11.80 to −0.21, P = 0.042), with a test of interaction not showing significance (P = 0.640). Further subgroup analyses showed no significance. Across all women there was a weak relationship between bile acid concentrations and itch severity. Conclusions: There was no subgroup of women with ICP in whom a beneficial effect of treatment with UDCA on bile acid concentration or itch score could be identified. This confirms that its routine use in women with this condition for improvement of bile acid concentration or itch score should be reconsidered. Tweetable abstract: PITCHES: No group of women with ICP has been found in whom UDCA reduces bile acid concentrations or pruritus.

Text
BJOG - 2020 - Fleminger - Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy a secondary analysis of the - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 8 October 2020
e-pub ahead of print date: 16 October 2020
Published date: 9 April 2021
Additional Information: Funding Information: The trial was funded by the National Institute for Health Research Efficacy and Mechanism Evaluation Programme (Reference 12/164/16), following external peer review, including patient and public review. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: LCC is funded by the National Institute for Health Research (NIHR) Professorship, RP‐2014–05–019. Paul T Seed is partly funded by King’s Health Partners Institute of Women and Children’s Health, Tommy’s (Registered charity no. 1060508) and by ARC South London (NIHR). The views expressed in this publication are those of the authors and not necessarily those of KHP, Tommy's, the NHS, the NIHR or the Department of Health. We thank the independent Trial Steering Committee (David Williams, Judith Hibbert, Julia Sanders, Deborah Stocken, Julian Walters, Win Tin) and the independent Data Monitoring Committee (John Norrie, William McGuire, Jenny Myers). Funding Information: The trial was funded by the National Institute for Health Research Efficacy and Mechanism Evaluation Programme (Reference 12/164/16), following external peer review, including patient and public review. The trial was funded by the National Institute for Health Research Efficacy and Mechanism Evaluation Programme (Reference 12/164/16), following external peer review, including patient and public review. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LCC is funded by the National Institute for Health Research (NIHR) Professorship, RP-2014–05–019. Paul T Seed is partly funded by King’s Health Partners Institute of Women and Children’s Health, Tommy’s (Registered charity no. 1060508) and by ARC South London (NIHR). The views expressed in this publication are those of the authors and not necessarily those of KHP, Tommy's, the NHS, the NIHR or the Department of Health. We thank the independent Trial Steering Committee (David Williams, Judith Hibbert, Julia Sanders, Deborah Stocken, Julian Walters, Win Tin) and the independent Data Monitoring Committee (John Norrie, William McGuire, Jenny Myers). Publisher Copyright: © 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd
Keywords: Cholestasis, perinatal, pregnancy, stillbirth, ursodeoxycholic acid

Identifiers

Local EPrints ID: 485434
URI: http://eprints.soton.ac.uk/id/eprint/485434
ISSN: 1470-0328
PURE UUID: a3cf6d1d-2fcb-469e-8014-ec2e5ccdedf5
ORCID for J. Dorling: ORCID iD orcid.org/0000-0002-1691-3221

Catalogue record

Date deposited: 06 Dec 2023 17:41
Last modified: 18 Mar 2024 04:17

Export record

Altmetrics

Contributors

Author: J. Fleminger
Author: P. T. Seed
Author: A. Smith
Author: Edmund Juszczak
Author: P. H. Dixon
Author: J. Chambers
Author: J. Dorling ORCID iD
Author: Catherine Williamson
Author: J. G. Thornton
Author: L. C. Chappell

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×